Long-term prognostic and predictive factors in 107 stage II/III breast cancer patients treated with anthracycline-based neoadjuvant chemotherapy. - Brain,E.; Garrino,C.; Misset,J.L.; Carbonero,I.G.; Itzhaki,M.; Cvitkovic,E.; Goldschmidt,E.; Burki,F.; Regensberg,C.; Pappo,E.; Hagipantelli,R.; Musset,M. (Br J Cancer, 1997)